M J Hezzell
Treatment of dogs with compensated myxomatous mitral valve disease with spironolactone-a pilot study
Hezzell, M J; Boswood, A; Lopez-Alvarez, J; Lotter, N S; Elliott, J
Authors
A Boswood
J Lopez-Alvarez
N S Lotter
J Elliott
Abstract
Spironolactone improves outcome in dogs with advanced myxomatous mitral valve disease (MMVD). Its efficacy in preclinical MMVD is unknown. The hypothesis was the administration of spironolactone to dogs with compensated MMVD demonstrating risk factors for poorer prognosis will decrease the rate of disease progression. The aim was to provide pilot data to evaluate preliminary effects and sample size calculation for a definitive clinical trial.
Citation
Hezzell, M. J., Boswood, A., Lopez-Alvarez, J., Lotter, N. S., & Elliott, J. (2017). Treatment of dogs with compensated myxomatous mitral valve disease with spironolactone-a pilot study. Journal of Veterinary Cardiology, 19(4), 325-328. https://doi.org/10.1016/j.jvc.2017.06.001
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 15, 2017 |
Publication Date | Jul 19, 2017 |
Deposit Date | Aug 22, 2017 |
Publicly Available Date | Aug 1, 2018 |
Journal | Journal of Veterinary Cardiology |
Print ISSN | 1760-2734 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 19 |
Issue | 4 |
Pages | 325-328 |
DOI | https://doi.org/10.1016/j.jvc.2017.06.001 |
Public URL | https://rvc-repository.worktribe.com/output/1391211 |
Files
10924.pdf
(1 Mb)
PDF
You might also like
The effect of myxomatous mitral valve disease severity on packed cell volume in dogs
(2021)
Journal Article
Downloadable Citations
About RVC Repository
Administrator e-mail: publicationsrepos@rvc.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search